• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[β-肾上腺素能阻滞剂在接受冠状动脉旁路移植术的缺血性心脏病患者中应用的临床-药物经济学方面]

[Clinical-pharmacoeconomical aspects of ß-adrenoblockers use in patients with ischemic heart disease undergoing coronary artery bypass grafting].

作者信息

Lopatin Iu M, Dronova E P

出版信息

Kardiologiia. 2010;50(9):15-22.

PMID:21118161
Abstract

Aim of this study was to assess clinical and pharmacoeconomic effects of long term use of adrenoblockers in patients with ischemic heart disease (IHD) undergoing coronary artery bypass grafting. Patients with IHD (n=294) were included in open, prospective, randomized clinical trial. The follow up period was 3 years. It was noted that long term use of bisoprolol in comparison with atenolol and metoprolol was characterized by more pronounced increase of exercise tolerance, lower rate of angina recurrence and lower expenses for treatment of patients with IHD.

摘要

本研究的目的是评估长期使用肾上腺阻滞剂对接受冠状动脉搭桥术的缺血性心脏病(IHD)患者的临床和药物经济学效果。将IHD患者(n = 294)纳入开放、前瞻性、随机临床试验。随访期为3年。结果发现,与阿替洛尔和美托洛尔相比,长期使用比索洛尔的特点是运动耐量增加更为显著,心绞痛复发率更低,IHD患者的治疗费用更低。

相似文献

1
[Clinical-pharmacoeconomical aspects of ß-adrenoblockers use in patients with ischemic heart disease undergoing coronary artery bypass grafting].[β-肾上腺素能阻滞剂在接受冠状动脉旁路移植术的缺血性心脏病患者中应用的临床-药物经济学方面]
Kardiologiia. 2010;50(9):15-22.
2
Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients.比索洛尔的选择性β1-受体拮抗作用与阿替洛尔或美托洛尔相比,术后中风的发生率更低:一项对 44092 例连续患者的单中心队列研究。
Anesthesiology. 2013 Oct;119(4):777-87. doi: 10.1097/ALN.0b013e3182a17f12.
3
Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.比索洛尔或阿替洛尔对慢性阻塞性支气管炎患者心绞痛的长期治疗:一项随机、双盲交叉研究。
J Cardiovasc Pharmacol. 1990;16 Suppl 5:S36-44.
4
[Clinical-pharmacoeconomic aspects of trimetazidine modified release use in patients with ischemic heart disease undergoing coronary artery bypass grafting].[曲美他嗪缓释片在接受冠状动脉搭桥术的缺血性心脏病患者中应用的临床药物经济学方面]
Kardiologiia. 2009;49(2):15-21.
5
A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
Int J Clin Pharmacol Ther Toxicol. 1991 Apr;29(4):139-43.
6
Does β selectivity really affect outcome?
Anesthesiology. 2014 May;120(5):1286-7. doi: 10.1097/ALN.0000000000000195.
7
Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.美托洛尔对冠状动脉旁路移植术后2年内心脏死亡及心脏事件的影响。MACB研究组。
Eur Heart J. 1995 Dec;16(12):1825-32.
8
In reply.
Anesthesiology. 2014 May;120(5):1287-8. doi: 10.1097/ALN.0000000000000196.
9
[Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].不同β受体阻滞剂对合并糖尿病及阻塞性肺疾病的单纯收缩期高血压患者的疗效及安全性
Ter Arkh. 2003;75(8):43-7.
10
Patient safety: anesthesiology contributions and supplements to the American Society of Anesthesiologists' Annual Meeting.
Anesthesiology. 2013 Oct;119(4):745-6. doi: 10.1097/ALN.0b013e3182a5c413.